Simultaneous resection of colorectal cancer and liver metastases

ABSTRACT Although the presence of synchronous colorectal liver metastases (CRLM) represents an important prognostic factor for recurrence-free survival (RFS) and overall survival (OS), the definitions of synchronicity are variable in the literature, including metastases at the time of diagnosis, or even before the diagnostic of the primary site of colorectal cancer (CRC), until either six or 12 months after the time of diagnosis, according to the author of each study. Simultaneous approaches to treat CRC and CRLM seem to be safe for patients carefully selected without jeopardizing oncologic outcomes, with similar complication rates, shorter hospital length of stay, and operation times even for major hepatectomies. However, there is no consensus about the optimal timing to approach the primary tumor and CRLM, whether simultaneously or staged, and both performance status and the presence of symptoms play important roles in the treatment sequence, perhaps avoiding two high-risk procedures at the same time.

Authors

Institutions

Publication Details

Journal
ABCD Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)
Published
2025-01-01
DOI
https://doi.org/10.1590/0102-67202025000014e1883
Primary Topic
Hepatocellular Carcinoma Treatment and Prognosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Simultaneous resection of colorectal cancer and liver metastases

Aleksandar Karamarković, Marcelo Moura Linhares, Raphael L. C. Araújo, Olivier Soubrane et al.
ABCD Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)
Hepatocellular Carcinoma Treatment and Prognosis
article

Simultaneous resection of colorectal cancer and liver metastases

Aleksandar Karamarković, Marcelo Moura Linhares, Raphael L. C. Araújo, Olivier Soubrane, Timothy Michael Pawlik, Paulo Herman, Maria Ignez Braghiroli, Ricardo Lemos Cotta-Pereira, Hugo P. Marques, A.R. Teixeira, René A. Adam
article en

Abstract

ABSTRACT Although the presence of synchronous colorectal liver metastases (CRLM) represents an important prognostic factor for recurrence-free survival (RFS) and overall survival (OS), the definitions of synchronicity are variable in the literature, including metastases at the time of diagnosis, or even before the diagnostic of the primary site of colorectal cancer (CRC), until either six or 12 months after the time of diagnosis, according to the author of each study. Simultaneous approaches to treat CRC and CRLM seem to be safe for patients carefully selected without jeopardizing oncologic outcomes, with similar complication rates, shorter hospital length of stay, and operation times even for major hepatectomies. However, there is no consensus about the optimal timing to approach the primary tumor and CRLM, whether simultaneously or staged, and both performance status and the presence of symptoms play important roles in the treatment sequence, perhaps avoiding two high-risk procedures at the same time.

ABCD Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)Vol. 38
Délégation Paris 5 (FR), Universidade de São Paulo (BR), Université Paris Cité (FR), Université Paris-Saclay (FR), University of Belgrade (RS), Unidade Local de Saúde de São José (PT), D’Or Institute for Research and Education (BR), Fundação Instituto de Pesca do Estado do Rio de Janeiro (BR), The Ohio State University (US), Universidade Federal de São Paulo (BR)
Openalex Percentile: Top 75%
Hepatocellular Carcinoma Treatment and Prognosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.